Your browser doesn't support javascript.
loading
High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study.
Gare, Janet; Toto, Ben; Pokeya, Percy; Le, Linh-Vi; Dala, Nick; Lote, Namarola; John, Bangan; Yamba, Abel; Soli, Kevin; DeVos, Joshua; Paulin, Heather; Wagar, Nick; Zheng, Du-Ping; Nishijima, Takeshi; Boas, Peniel; Kelly-Hanku, Angela; Gurung, Anup.
Afiliación
  • Gare J; Sexual and Reproductive Health Unit, PNG Institute of Medical Research, Corner of Leigh Vial & Homate St, Goroka, Eastern Highlands Province, 441, Papua New Guinea. janet.gare@pngimr.org.pg.
  • Toto B; Sexual and Reproductive Health Unit, PNG Institute of Medical Research, Corner of Leigh Vial & Homate St, Goroka, Eastern Highlands Province, 441, Papua New Guinea.
  • Pokeya P; United States Centres for Disease Control and Prevention Country Office of Papua New Guinea, Port Moresby, National Capital District, Papua New Guinea.
  • Le LV; HIV, Hepatitis and STI Unit, Division of Communicable Disease, World Health Organization Regional Office of the Western Pacific, Manila, Philippines.
  • Dala N; Director's Office, National AIDS Council Secretariat, Port Moresby, National Capital District, Papua New Guinea.
  • Lote N; World Health Organization Country Office of Papua New Guinea, Port Moresby, National Capital District, Papua New Guinea.
  • John B; World Health Organization Country Office of Papua New Guinea, Port Moresby, National Capital District, Papua New Guinea.
  • Yamba A; United States Centres for Disease Control and Prevention Country Office of Papua New Guinea, Port Moresby, National Capital District, Papua New Guinea.
  • Soli K; United States Centres for Disease Control and Prevention Country Office of Papua New Guinea, Port Moresby, National Capital District, Papua New Guinea.
  • DeVos J; Division of Global HIV and TB, International Lab Branch, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Paulin H; Division of Global HIV and TB, HIV Care and Treatment Branch, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Wagar N; Division of Global HIV and TB, International Lab Branch, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Zheng DP; Division of Global HIV and TB, International Lab Branch, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Nishijima T; National Center for Global Health and Medicine, Tokyo, Japan.
  • Boas P; National HIV Program Division, National Department of Health, Port Moresby, National Capital District, Papua New Guinea.
  • Kelly-Hanku A; Sexual and Reproductive Health Unit, PNG Institute of Medical Research, Corner of Leigh Vial & Homate St, Goroka, Eastern Highlands Province, 441, Papua New Guinea.
  • Gurung A; Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, NSW, Australia.
BMC Infect Dis ; 22(1): 266, 2022 Mar 19.
Article en En | MEDLINE | ID: mdl-35305571

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Papúa Nueva Guinea Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Papúa Nueva Guinea Pais de publicación: Reino Unido